Chemoinformaics analysis of 2,5-Dimethoxy-9,10-dihydrophenanthrene-1,7-diol
| Molecular Weight | 272.3 | nRot | 2 |
| Heavy Atom Molecular Weight | 256.172 | nRig | 16 |
| Exact Molecular Weight | 272.105 | nRing | 3 |
| Solubility: LogS | -3.783 | nHRing | 0 |
| Solubility: LogP | 2.923 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 36 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 2 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 12 |
| nHA | 4 | APOL | 40.5967 |
| nHD | 2 | BPOL | 19.5233 |
| QED | 0.882 |
| Synth | 2.446 |
| Natural Product Likeliness | 1.67 |
| NR-PPAR-gamma | 0.907 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.01 |
| Pgp-sub | 0.313 |
| HIA | 0.006 |
| CACO-2 | -4.823 |
| MDCK | 0.0000172 |
| BBB | 0.053 |
| PPB | 0.955513 |
| VDSS | 0.678 |
| FU | 0.0380705 |
| CYP1A2-inh | 0.94 |
| CYP1A2-sub | 0.955 |
| CYP2c19-inh | 0.519 |
| CYP2c19-sub | 0.264 |
| CYP2c9-inh | 0.298 |
| CYP2c9-sub | 0.912 |
| CYP2d6-inh | 0.639 |
| CYP2d6-sub | 0.928 |
| CYP3a4-inh | 0.52 |
| CYP3a4-sub | 0.318 |
| CL | 11.271 |
| T12 | 0.744 |
| hERG | 0.052 |
| Ames | 0.252 |
| ROA | 0.151 |
| SkinSen | 0.717 |
| Carcinogencity | 0.057 |
| EI | 0.209 |
| Respiratory | 0.746 |
| NR-Aromatase | 0.815 |
| Antiviral | Yes |
| Prediction | 0.776751 |